MARSTON'S PLC

Director's Dealing • Jun 6, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5222Q

Marston's PLC

06 June 2018

Notification of interests of Director/PDMR

6 June 2018

Marston's PLC (the 'Company') announces that it has been notified that Andrew Andrea has today sold 183,441 shares in the Company and purchased them back into his SIPP.  There is no change to the total number of shares held by Mr Andrea as a result of these transactions.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation. 

Enquiries: Anne-Marie Brennan, Group Secretary, Marston's PLC, +44 (0)1902 329163

1.

Details of PDMR / PCA (person closely associated)

(a)

Name

Andrew Andrea and Emma Andrea

(b)

Position/status

PDMR (Executive Director) and PCA

(c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer

(a)

Name

Marston's PLC

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

ISIN GB00B1JQDM80

(b)

Nature of the transaction

Sale of shares by Andrew Andrea and Emma Andrea and immediate purchase into SIPP by Andrew Andrea.

(c)

Price(s) and volume(s)

Price(s)	Volume(s)
Sale at £0.9655	155,000
Sale at £0.9655	28,441
Purchase at £0.9655	183,441

(d)

Aggregated information

-  Aggregated volume

-  Price

Sale - 183,441

Purchase - 183,441

Sale at £0.9655

Purchase at £0.9655

(e)

Date of the transaction

2018-06-06

(f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEAAKKEFXPEFF